Chromane and chromene derivatives and uses thereof

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 311/58 (2006.01) A61K 31/353 (2006.01) A61P 25/18 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2605587

Compounds of formula I or pharmaceutically acceptable salts thereof are provided: wherein each of R1, R2, R3, R4, y, m, n, and Ar are as defined, and described in classes and subclasses herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.

L'invention concerne des composés de formule (I) ou des sels pharmaceutiquement acceptables de ces composés. Dans ladite formule (I), chaque R1, R2, R3, R4, y, m, n, et Ar sont tels que définis et sont décrits dans des catégories et sous-catégories figurant dans le descriptif de l'invention. Les composés selon l'invention sont des agonistes ou agonistes partiels des récepteurs cérébraux de la sérotonine de sous-type 2C. Lesdits composés, ainsi que des compositions contenant des composés peuvent être utilisés pour traiter une variété de troubles du système nerveux central tels que la schizophrénie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Chromane and chromene derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chromane and chromene derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromane and chromene derivatives and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1935935

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.